Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Cutting Edge: IL-6-Dependent Autoimmune Disease: Dendritic Cells as a Sufficient, but Transient, Source.
Minocycline attenuates experimental autoimmune encephalomyelitis in rats by reducing T cell infiltration into the spinal cord.
Disruption of oligodendrocyte gap junctions in experimental autoimmune encephalomyelitis.
Cerebrospinal fluid α-synuclein levels are elevated in multiple sclerosis and neuromyelitis optica patients during replase.
Treatment of Acute Disseminated Encephalomyelitis.
The CSF JCV antibody index for diagnosis of natalizumab-associated PML.
Vitamin D status and the risk of multiple sclerosis: A systematic review and meta-analysis.
Continuous prediction of secondary progression in the individual course of multiple sclerosis.
Validation of a new quality of life scale related to multiple sclerosis and relapses.
Overview of the epidemiology, diagnosis, and disease progression associated with multiple sclerosis.
Autologous hematopoietic stem cell transplantation in multiple sclerosis: A phase II trial.
Are more sphingosine 1-phosphate receptor agonists a better therapeutic option against multiple sclerosis?
Decrease in newly generated oligodendrocytes leads to motor dysfunctions and changed myelin structures that can be rescued by transplanted cells.
Review series on immune responses in neurodegenerative diseases: Oligodendrocyte-microglia cross-talk in the CNS.
Passive induction of experimental allergic encephalomyelitis.
Progressive multifocal leukoencephalopathy: an unexpected complication of modern therapeutic monoclonal antibody therapies.
Autoregulatory CD8 T cells depend on cognate antigen recognition and CD4/CD8 myelin determinants.
Prolonged-release fampridine in multiple sclerosis: Improved ambulation effected by changes in walking pattern.
Multiple sclerosis susceptibility loci do not alter clinical and MRI outcomes in clinically isolated syndrome.
B-cell-directed therapy: which B cells should be targeted and how?
The role of endogenous antiradical protective system in multiple sclerosis.
Transcriptional targeting of DCs with lentiviral vectors induces antigen-specific tolerance in a mouse model of multiple sclerosis.
MENGA: A New Comprehensive Tool for the Integration of Neuroimaging Data and the Allen Human Brain Transcriptome Atlas.
Common and Low Frequency Variants in MERTK Are Independently Associated with Multiple Sclerosis Susceptibility with Discordant Association Dependent upon HLA-DRB1*15:01 Status.
Cognitive performance of neuromyelitis optica patients: comparison with multiple sclerosis.
Pages
« first
‹ previous
…
206
207
208
209
210
211
212
213
214
…
next ›
last »